Chimerix to drop development of brincidofovir for Ebola

Chimerix to drop development of brincidofovir for Ebola


US antiviral biopharma company Chimerix says that, after discussion with the US Food and Drug Administration,…

Anti-viralsBiotechnologybrincidofovirChimerixResearchTropical diseasesUSA

NewLink Genetic and Merck Ebola collaboration gets $30 million government award


US biotech firm NewLink Genetics saw its shares gain 4.1% to $40.11 in morning trading on Monday, following…

Anti-viralsBiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesUSA

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture


Denmark and USA-based contract manufacturers CMC Biologics and US biopharma start-up OncoSynergy have…

Anti-viralsBiotechnologyCMC BiologicsOncoSynergyOS2966ProductionResearchTropical diseases

US declaration under PREP Act to support Ebola vaccines development


US Health and Human Services Secretary Sylvia Burwell yesterday announced a declaration under the Public…

Anti-viralsBavarian NordicBiotechnologyGlaxoSmithKlineJanssenJohnson & JohnsonLegalNewLink GeneticsResearchTropical diseasesUSAVaccines

Merck gains rights to NewLink Genetics investigational Ebola vaccine


US pharma giant Merck & Co has entered into an exclusive worldwide license agreement to research, develop,…

Anti-viralsBiotechnologyGlobalLicensingMerck & CoNewLink GeneticsResearchrVSV-EBOYTropical diseases

Scripps Research Institute scientists reveal weak spots in Ebola's defenses


Scientists at The Scripps Research Institute (TSRI) have identified weak spots on the surface of Ebola…

Anti-viralsBiotechnologyMapp BiopharmaceuticalResearchTropical diseasesZMapp

US HHS contracts with Mapp Biopharmaceutical to develop Ebola drug


The US Department of Health and Human Services has awarded a $25 million contract to Mapp Biopharmaceutical…

Anti-viralsBiotechnologyFinancialMapp BiopharmaceuticalResearchTropical diseasesUSAZMapp

GenVec presents encouraging data from malaria vaccine study


In an announcement that has been widely anticipated, Maryland, USA-based biotechnology firm GenVec presented…

BiotechnologyGenVecPharmaceuticalResearchTropical diseasesVaccines

Back to top